
11 - 50 employees
Founded 2008
🏥 Healthcare
đź’Ľ Consulting
🎖️ Defense
đź’° $200M Post-IPO Equity - Immuneering on 2025-09
Healthcare • Consulting • Defense
Immuneering Corporation is a clinical-stage biotechnology company developing a novel class of oncology therapies called Deep Cyclic Inhibitors, which use rhythmic dosing to outpace cancer adaptation, improve tolerability, and extend patient survival and quality of life. The company advances a pipeline through clinical trials, collaborates with partners, and emphasizes scientific research and publications to transform cancer treatment while reducing side effects of traditional continuous-inhibition therapies.
đź•’ September 22
🏄 California, New York, +1 more states – Remote
đź’µ $170k - $210k / year
⏰ Full Time
đźź Senior
đź‘” Director
đź‘» Ghost score 0%
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
Founded 2008
🏥 Healthcare
đź’Ľ Consulting
🎖️ Defense
đź’° $200M Post-IPO Equity - Immuneering on 2025-09
Healthcare • Consulting • Defense
Immuneering Corporation is a clinical-stage biotechnology company developing a novel class of oncology therapies called Deep Cyclic Inhibitors, which use rhythmic dosing to outpace cancer adaptation, improve tolerability, and extend patient survival and quality of life. The company advances a pipeline through clinical trials, collaborates with partners, and emphasizes scientific research and publications to transform cancer treatment while reducing side effects of traditional continuous-inhibition therapies.
• Oversee all aspects of the drug product development program from candidate nomination through clinical development • Conduct pre-formulation studies, including API form characterization and selection, with Process Chemistry • Design, execute and interpret formulation screening and excipient selection studies • Define phase-appropriate formulation approaches balancing clinical needs, manufacturability, regulatory expectations and commercial considerations • Develop robust, scalable and cost-effective drug product manufacturing processes • Direct drug product process development, technology transfer and manufacturing campaigns at external CDMOs • Review and approve process development protocols, master batch records, manufacturing campaign reports, executed batch records, quality investigations and batch disposition records • Provide person-in-plant support for manufacturing campaigns as required • Assist in establishing critical quality attributes and critical process parameters • Author or review development reports and risk assessments • Author assigned CMC sections for IND, IMPD, NDA and MAA filings and respond to regulatory agencies • Serve as drug product subject matter expert for cross-functional teams • Collaborate across CMC and the wider development team to deliver quality drug product for clinical trials • Maintain technical expertise in formulation and process development • Work in compliance with cGMP, safety and regulatory requirements • Report to the Head of CMC
• PhD in pharmaceutics, pharmaceutical sciences, chemical engineering, chemistry or related discipline with 8+ years of industry experience; or MS or BS degree in a related discipline with 12+ years of industry experience • Foundational understanding of pre-formulation studies, formulation design and development, and drug product manufacturing process development • Experience developing formulations for poorly soluble BCS Class II/IV compounds • Experience in drug product technology transfer and manufacture • Experience managing CDMOs for research, development and manufacturing campaigns • Solid understanding of FDA, EMA, and ICH regulatory guidelines • Ability to apply regulatory guidance to practical solutions and development strategies • Exceptional decision-making skills and ability to work independently in a fast-paced, high-pressure setting • Excellent technical writing skills, including regulatory submissions and responses to regulatory questions • Values-based leadership and commitment to integrity and ethics in pharmaceutical product development and manufacture • Preferred: background in dry/wet granulation, extrusion, spray drying, tableting and coating • Preferred: understanding of physicochemical and biopharmaceutical properties related to formulation design • Preferred: QbD, QTPP, CQA, CMA, CPP, FMEA and risk assessment experience • Preferred: pediatric formulation development • Preferred: HPLC, LC-MS, XRPD, DSC, dissolution and KF • Preferred: IND/IMPD and NDA/MAA submissions • Preferred: managing quality investigations
• Remote work • Travel: 10 to 20% • Inclusive and collaborative, mission-driven culture • Equal opportunity employment
Apply Nowđź•’ September 22
Sr. Director leading Chronosphere’s global pre-sales organization for cloud-native observability. Scaling sales engineering, guiding enterprise deal strategy, and aligning technical execution with Palo Alto Networks’ cybersecurity mission.
🇺🇸 United States – Remote
đź’µ $389.7k - $454.6k / year
đź’° $1M Seed Round - Morta Security on 2013-02
⏰ Full Time
đźź Senior
đź‘” Director
🦅 H1B Visa Sponsor
đź•’ September 21
Senior Director leading GCP compliance and inspection readiness for Absci, a generative-AI biotechnology company. Driving clinical-trial oversight, remediation, audits, and regulatory preparedness.
đź•’ September 21
Novartis oncology account leader driving product adoption across priority healthcare accounts in Utah and Nevada. Developing strategic plans, executive relationships, and cross-functional launch initiatives.
🇺🇸 United States – Remote
đź’µ $168k - $312k / year
⏰ Full Time
đźź Senior
đź‘” Director
🦅 H1B Visa Sponsor
đź•’ September 21
Head of Integrations leading partner product strategy for G-P’s global employment SaaS platform. Driving enterprise integrations, adoption, revenue, and AI-enabled partner solutions.
đź•’ September 21
Associate Director optimizing field analytics, targeting, territories, and sales-force effectiveness for BeOne Medicines’ oncology products. Translating commercial data into actionable pharmaceutical growth strategies.